Status:
RECRUITING
Impact in Head and Neck Oncology of Support by a Nurse in the Patient's Care Pathway
Lead Sponsor:
University Hospital, Toulouse
Conditions:
Head and Neck Cancer
Eligibility:
All Genders
18+ years
Brief Summary
Head and neck cancers (HNC) constitute a significant global health burden, ranking fourth in terms of cancer incidence and fifth in terms of cancer-related mortality. The management of HNC requires a ...
Detailed Description
This study is a prospective monocentric comparative investigation conducted over 12 months. Two groups are being compared: the COACH group and the control group. The COACH group consists of newly diag...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- Patient with a histologically proven diagnosis of head and neck squamous cell carcinoma (HNSCC) of the upper aerodigestive tract
- Patient whose disease is classified UICC (Union for International Cancer Control (UICC) Tumour, Node, Metastasis (TNM) stage (8th edition): T0-4a NO/N3 M0 (no distant metastasis M0)
- Patient World Health Organization (WHO) 0-1-2
- Treatment with a feasible curative aim (no contraindication to optimal treatment such as surgery or chemotherapy at a curative dose)
- Patient affiliated to a Social Security scheme in France
- Patient who did not object to participating in the research.
- Non-inclusion criteria:
- Patient with a history of previous cervical surgery and/or head and neck irradiation
- Pregnant or breastfeeding women
- Patient suffering from another co-existing malignant disease at the time of inclusion or any other significant medical (immunosuppression etc.), psychiatric or surgical condition, currently not controlled by treatment, which may interfere with the achievement of the study.
- Any psychological, family, geographic or sociological condition that does not allow compliance with medical monitoring and/or the procedures provided for in the study protocol.
- Patients deprived of liberty or under legal protection regime (curatorship and guardianship, safeguard of justice).
Exclusion
Key Trial Info
Start Date :
February 20 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
February 28 2025
Estimated Enrollment :
320 Patients enrolled
Trial Details
Trial ID
NCT06203808
Start Date
February 20 2024
End Date
February 28 2025
Last Update
April 4 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Chu de Toulouse
Toulouse, France